To the G20: incentivising antibacterial research and development
- 1 August 2017
- journal article
- editorial
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 17 (8) , 799-801
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approachThe Lancet Infectious Diseases, 2016
- Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfoldsEurosurveillance, 2016
- Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling studyThe Lancet Infectious Diseases, 2015
- Drugs for bad bugs: confronting the challenges of antibacterial discoveryNature Reviews Drug Discovery, 2006